Eigo Akimoto

National Cancer Center Hospital East

Papers

3

Total Citations

52

H-Index

3

About

Eigo Akimoto is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for gastric cancer treatment. His major contributions center on evaluating the clinical benefits of robotic gastrectomy (RG) compared to conventional laparoscopic and open surgery. In a landmark 2021 case–control study (41 citations), Akimoto demonstrated that robotic surgery significantly reduces postoperative complications, establishing RG as a safer alternative despite higher costs and longer operative times. He further showed that overweight patients derive particular advantages from robotic gastrectomy (2023, 6 citations), with improved ergonomics and precision leading to better outcomes. Expanding the scope of minimally invasive approaches, Akimoto’s 2024 study (5 citations) confirmed the feasibility of laparoscopic and robot-assisted surgery for Borrmann type 4 gastric cancer—a traditionally challenging tumor subtype—achieving comparable results to open surgery. His work has helped define patient populations most likely to benefit from robotic techniques and has influenced surgical guidelines for gastric cancer management. With a growing citation impact, Akimoto continues to shape the evolution of robotic oncologic surgery.

Research Focus

Key Achievements

3
H-Index
3
Papers
52
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Reduction in postoperative complications by robotic surgery: a case–control study of robotic versus conventional laparoscopic surgery for gastric cancer
41 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: National Cancer Center Hospital East

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago